Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Veterinary Research

Open Access

Optimized gating and reference ranges of reticulated platelets in dogs for the Sysmex XT-2000iV

  • Dana E. Oellers1Email author,
  • Natali Bauer1,
  • Melanie Ginder2,
  • Sigrid Johannes3,
  • Iris Pernecker3 and
  • Andreas Moritz1
BMC Veterinary ResearchBMC series – open, inclusive and trusted201612:148

https://doi.org/10.1186/s12917-016-0779-4

Received: 2 June 2015

Accepted: 20 July 2016

Published: 22 July 2016

Abstract

Background

Canine reticulated platelets (r-PLTs) i.e., juvenile PLTs reflecting thrombopoiesis can be measured automatically with the hematology analyzer Sysmex XT-2000iV using manual gating options. However, the impact of interferences on r-PLT measurements performed with the gates published previously (Pankraz et al., Vet Clin Path 38:30–38, 2009; Gelain et al., High fluorescent platelets fraction in macrothrombocytopenic Norfolk terrier, 2010) is largely unknown.

The aim was to compare different published gates for measurement of r-PLTs with the Sysmex XT-2000iV with an own, optimized gate (“Oellers-gate”) and to establish reference intervals (RIs) in > 120 dogs.

Data of 362 measurements of diseased and healthy dogs were analyzed retrospectively. Several gates were applied and RIs for r-PLTs and platelet indices were established for pet dogs and a group of 153 healthy Beagles kept under defined housing conditions. Intra-assay precision (CV) was also assessed.

Results

In 30/362 samples, interferences consistent with small erythrocytes/reticulocytes were seen in the previously published gates but not in the “Oellers-gate”. Good correlation was found between the different gates (rs: 0.88–1.00). RIs for the “Pankraz-gate”, the “Gelain-gate”, and the “Oellers-gate” were 0.0–1.2, 0.2–3.7 and 0.2–3.9 % respectively. CVs were ranging between 22 and 41 %.

Conclusions

Optimization of previously published gates minimized interferences of small erythrocytes with r-PLT measurements.

Keywords

RNA-rich plateletsCanineHematology analyzer

Background

Canine reticulated platelets (r-PLTs) i.e., juvenile platelets were first described in 1969 following acute blood loss in dogs [1]. Later, r-PLTs were detected with flow cytometry using Thiazol Orange [2] comparable to the measurement of reticulocytes [3]. Thiazol Orange positive platelets are shown to be less than 24 h old [4], so that their measurement is useful to estimate the platelet production by the bone marrow as it has been shown for human patients [5, 6]. Megakaryopoiesis can be estimated by evaluating a bone marrow aspirate or biopsy; however, taking a blood sample is much easier, less invasive and therefore the better choice for a continuous monitoring of the patient. Moreover, evaluation of bone marrow samples is subjective, time consuming and requires a highly skilled examiner. Measuring r-PLTs in whole blood using flow cytometry with Thiazol Orange is noninvasive and objective, but the method is both expensive and time-consuming. The Sysmex XE-2100 and the closely related Sysmex XT-2000iV are automated hematology analyzers designed for their use in human and animal specimens, respectively. Both analyzers measure platelets by impedance (PLT-I) and laser based methods (PLT-O). Due to its option of manual gating, the Sysmex analyzer XT-2000iV is capable of detecting immature r-PLTs by flow cytometry in the PLT-O channel, whereby a proprietary dye containing polymethine and oxazine is applied. The dye penetrates cell membranes and stains nucleic acids in reticulocytes and immature platelets. These cells are classified by flow cytometry based on their size (forward light scatter) and their fluorescence intensity (nucleic acid content) [7]. Since 2009, the detection of r-PLTs in dogs with the Sysmex XT-2000iV automated hematology analyzer has been evaluated and a reference interval has been established (n = 40 dogs [8] and 86 dogs respectively [9]).

Similar to human medicine [10], a large reference population of > 120 reference individuals has been recommended also in veterinary medicine to reliably establish reference intervals (ASVCP recommendations) [11]. To the authors’ knowledge, reference intervals based on such a large reference population have not been established for r-PLTs and platelet indices for the Sysmex XT-2000iV (thereafter XT-2000iV) analyzer before. Moreover, the impact of potentially interfering cell populations such as small erythrocytes and reticulocytes on r-PLT measurements performed with the manual gates published previously is largely unknown.

Several platelet indices such as mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR) and plateletcrit (PCT) are provided automatically by the XT-2000iV with each measurement. The diagnostic use of platelet indices reflecting platelet size as marker for juvenile platelets has been controversially discussed [1217]. We previously demonstrated that there was no difference between platelet indices assessed with the XT-2000iV in thrombocytopenic dogs and controls despite a significantly higher percentage of r-PLTs observed in the diseased dogs [8]. However, the number of dogs evaluated previously was comparatively small (n = 40 control dogs, n = 8 thrombocytopenic dogs) so that a potential association between mean platelet volume (MPV) and the number of r-PLTs might have been missed. In contrast, the MPV was significantly higher in dogs with immune mediated thrombocytopenia than in healthy control dogs [18].

The aims of our study were 1) to compare an optimized gate with the two previously published gating methods [8, 9], 2) to assess the impact of potentially interfering cellular populations on r-PLT measurements, 3) to optimize the gates for measurement of r-PLTs with the XT-2000iV to eliminate possible interferences, and 4) to establish reference intervals for r-PLTs measured with the own and the previously published gating methods as well as for platelet indices in a reference population of > 120 dogs as recommended by the ASVCP [11].

Methods

Data of 362 canine complete blood cell counts (CBCs) including 14 follow-up samples was analyzed retrospectively. Follow-up samples are defined as blood samples, which have been taken from the same diseased dog but at different dates. The blood samples have been collected between July 2006 and April 2007 in the department of veterinary clinical sciences, Giessen, Germany and between June 2009 and February 2010 in the department of Global Non-Clinical Safety, Merck Serono, Darmstadt, Germany. Overall, 169/362 samples were obtained from diseased dogs and 193/362 samples were taken from healthy dogs respectively.

Analysis of r-PLTs and PLT parameters

Measurement was performed with ethylenediamine tetra-acetic acid (EDTA) anticoagulated blood samples using the XT-2000iV hematology analyzer and the veterinary software version 00–08 and 00–10. The retrospective analysis and gating was performed using the veterinary software version 00–11. To detect the number of r-PLTs in the blood samples, we created one gate to quantify the whole platelet population (Fig. 1 and 2, PLT-O total) and another gate located inside the first gate (Figs. 1 and 2, red gate) containing the r-PLTs. A modified version of the “Gelain-gate” was created to optimize the separation between mature and r-PLTs as well as to exclude erythrocytes and reticulocytes. This modified gate (“Oellers-gate”, Fig. 1c) was compared with the gates published by Pankraz et al. and Gelain et al. (“Pankraz-gate” Fig. 1b and Fig. 2b and e, “Gelain-gate” Fig. 1a and Fig. 2a and d). The risk of small erythrocytes and/or reticulocytes causing clinically important interferences and thus a false r-PLT count was given when gate 4 (Fig. 1) contained more than 5 % of the sum of dots measured in gates 1 and 4. The suspicion of potential interferences of small erythrocytes/reticulocytes with the r-PLT count was confirmed by visual control of the matching scattergram.
Fig. 1

Schematic diagram showing the applied gates: “Gelain-gate” (a), “Pankraz-gate” (b) and “Oellers-gate” (c). Abbreviations: FSC, forward scatter; SFL, fluorescence intensity; RBC, erythrocytes; LFR, MFR, HFR, low, medium and high fluorescence ratio of reticulocytes; PLT, platelets; r-PLT, reticulated platelets; PLT-O total, green gate with all optically measured platelets; red gate, gate with r-PLTs; pink gate 4, gate with frequent interferences in the “Gelain-gate” and “Pankraz-gate”; white gate, can be ignored, not part of respective measurements

Fig. 2

Scattergrams of the PLT-O channel of the Sysmex XT-2000iV analyzing whole blood samples of a healthy dog (a-c) and a dog with increased platelet and r-PLT count (d-f). The applied gates are shown schematically. PLT Total detects all platelets, (a, d) r-PLT “Gelain – gate” based on publication of Gelain et al., (b, e) r-PLT “Pankraz-gate” based on the publication of Pankraz et al., (c, f) r-PLT “Oellers-gate” shows the novel area for counting r-PLTs. Abbreviations: FSC, forward scatter; SFL, fluorescence intensity

Retrospective analysis of each CBC included the following variables: platelet count by optical (PLT-O) and impedance methods (PLT-I), MPV, platelet distribution width (PDW), platelet large cell ratio (P-LCR), and plateletcrit (PCT).

The analyzer-specific canine reference intervals established previously for the XT-2000iV [19] were used as cut-off values to define anemia or regeneration of erythrocytes (i.e., anemia was diagnosed when the RBC count was < 5.1 × 1012/L and a reticulocyte count > 150.1 × 109/L was considered regenerative).

Reference population

The CBCs obtained from healthy dogs (n = 193, one sample per dog) included mainly samples taken from healthy Beagle dogs (153/193) obtained from one breeder (Marshall BioResources, USA). The Beagle dogs were kept under defined housing conditions: For 20 h a day, they were housed in groups of three to five dogs. Each dog spent the remaining four hours separated from the others in a standard kennel of 6.54 m2 and natural light. The Beagle dogs were fed once a day with 300 g of a commercially available pelleted dry food (Provimi Kliba AG, Kaiseraugust, Switzerland). Water was offered ad libitum. All Beagle dogs were dewormed and vaccinated against canine distemper, leptospirosis, canine parvovirus, parainfluenza, Bordetella, canine adenovirus 2, and rabies.

The other 40/193 healthy dogs kept as pet dogs were of various breeds including mixed-breed dogs (n = 17), Border Collies (n = 6), Great Danes (n = 3), West Highland White Terrier (n = 2), and one Beagle dog, Berger Blanc Suisse, Cocker Spaniel, Dalmatian, German Shepherd, Golden Retriever, Groenendael, Jack Russel Terrier, Labrador Retriever, Old German Shepherd Dog, Rough Collie, and Small Munsterlander each.

Statistical analysis

Data was analyzed using Microsoft Excel®, Reference Value Adviser© version 2.1 for Microsoft Excel®, Analyse-it® version 2.04 for Microsoft Excel®, and GraphPad Prism® version 6. Data distribution was assessed visually with a histogram.

Spearman’s rank correlation, Passing-Bablok-Analysis, and Bland-Altman-Analysis were performed to determine correlation and bias between r-PLTs measurements obtained with the various gates. A Kruskal-Wallis-Test was used to assess the impact of the gating method on r-PLT results, whereby the P values were adapted for multiple comparisons. Level of significance was set at P < 0.05.

Intra-assay repeatability was assessed by 25 repeated measurements of one blood sample. For platelet indices, the XT-2000iV did not report results in 18/25 measurements so that calculation of intra-assay CV was based on 7 results.

Reference intervals for r-PLTs and platelet indices were generated for all healthy dogs independent of the breed (n = 193), and also for the subgroups “Beagles” (n = 153) and “non-Beagles” (n = 40). As recommended by the American Society of Veterinary Clinical Pathology (ASVCP) [11], the statistical method used for calculation of the respective reference intervals was chosen based on the number of dogs included in the respective reference population and data distribution. The whole group of healthy dogs (n = 193) and the group of Beagle dogs (n = 153) included ≥ 120 individuals, so that the nonparametric method was chosen to calculate reference intervals [11]. The group of pet dogs contained 40 (r-PLT, PLT-O, PLT-I) and 38 (MPV, PDW, P-LCR, PCT) dogs, respectively. When the number of samples was 40 ≤ × ≤ 120, the robust method was chosen for symmetrical (Gaussian) data distribution [11]. In case of non-Gaussian distribution, a Box-Cox transformation was performed prior to calculation of reference intervals. Depending on data distribution after Box-Cox transformation, a the parametric method was chosen for data with Gaussian distribution, while a nonparametric method was used in case of non-Gaussian distribution. As the XT-2000iV did not report MPV, PDW, P-LCR and PCT for 3/193 healthy dogs, data of merely 38/40 samples was available in the group of “non-Beagles” for these variables. As recommended previously for reference populations of < 40 individuals [11], the parametric method and robust method were used in case of Gaussian and non-Gaussian distribution, respectively. For all reference intervals, the 90 % confidence interval (CI) of the upper and lower ends of the reference limits was calculated using bootstrap methods.

Results

The group of healthy Beagles included dogs with an age ranging from 10 to 14 months and equally distributed sex (77/153 intact males and 76/153 intact females).

In the group of healthy “non-Beagles”, 40 dogs (11/40 intact males, 7/40 castrated males, 5/40 intact females, as well as 17/40 castrated females) with a median age of two years (range: 4 months to 15 years) were enrolled.

In contrast, the diseased dogs (169/362) had a median age of seven years ranging between 3 months and 16 years. Overall, 60/169 intact males, 25/169 castrated males, 42/169 intact females as well as 42/169 castrated females were included.

In all 362 CBCs obtained from healthy and diseased dogs, the PLT count ranged between 3 × 109/L and 871 × 109/L. The r-PLT count as measured with the “Oellers-gate” ranged between 0.12 and 57.34 % in the whole group of 362 healthy and diseased dogs and between 0.29 and 57.34 % when regarding the group of diseased dogs alone (169/362).

The categories of underlying diseases are shown in Table 1. Overall, 41/169 samples were anemic with RBC counts < 5.1 × 1012 /L, whereby 19/41 anemic specimen showed regeneration of erythrocytes at the time of sampling with reticulocyte counts (RET) > 150.1 × 109/L.
Table 1

Classification in categories of underlying etiology in diseased dogs

Category of disease

Absolute number (percentage)

Inflammatory diseases

31 (19.87 %)

Cardiovascular diseases

20 (12.82 %)

Neoplasia

18 (11.54 %)

Diseases of the musculoskeletal system

17 (10.90 %)

Monitoring after surgery

8 (5.13 %)

Immune-mediated diseases

 

 - Immune mediated anemia (n = 4/8)

 - Immune mediated thrombocytopenia (n = 3/8)

 - Evans syndrome (n = 1/8)

8 (5.13 %)

Portosystemic shunt

6 (3.85 %)

Diseases of the central nervous system

4 (2.56 %)

Non-regenerative anemia

4 (2.56 %)

DIC

2 (1.28 %)

Endocrinologic disease

2 (1.28 %)

Thrombosis

2 (1.28 %)

Regenerative anemia (unknown etiology)

1 (0.64 %)

Hemolytic anemia (unknown etiology)

1 (0.64 %)

Other diseases

32

Abbreviations: DIC disseminated intravascular coagulation

All three evaluated gates of the XT-2000iV showed good correlation as shown in Table 2. The best correlation was found between the “Gelain-gate” and the “Oellers-gate”. There was a small bias between the results obtained with the “Gelain-gate” and the “Oellers-gate”; however, the difference was not statistically significant (Table 2). In contrast, the “Pankraz-gate” differed significantly from the two other gates and there was a bias of approximately 2 %. The corresponding median value and range are shown in Table 3.
Table 2

Correlation and differences between the different gates for canine r-PLT measurement (n = 362) of the Sysmex XT-2000iV

Variable

rs

Slope (95 % CI)

Intercept (95 % CI)

Bias (95 % limits of agreement)

Adjusted P-value

r-PLT “Gelain-gate”(%) vs. r-PLT “Oellers-gate”(%)

1.00

1.01 (1.01–1.01)

0.00 (0.00–0.00)

0.1 (−1.3–1.6)

ns

r-PLT “Pankraz-gate”(%) vs. r-PLT “Gelain-gate”(%)

0.89

2.83 (2.70–2.99)

0.18 (0.12–0.23)

2.0 (−4.3–8.3)

<0.0001

r-PLT “Pankraz-gate”(%) vs. r-PLT “Oellers-gate”(%)

0.88

2.92 (2.78–3.11)

0.17 (0.10–0.22)

2.1 (−4.9–9.2)

<0.0001

Abbreviations: CI confidence interval, ns not significant, vs. versus

Table 3

Median, minimum and maximum r-PLT counts of the analyzed group of healthy and diseased dogs (n = 362)

Variable

Median

Minimum

Maximum

r-PLT “Gelain-gate”(%)

1.33

0.11

54.89

r-PLT “Pankraz-gate”(%)

0.40

0.0

35.02

r-PLT “Oellers-gate”(%)

1.33

0.12

57.34

In 30/362 samples, a number of dots exceeding 5 % of the sum of dots in gates 1 and 4 was found in gate 4 (Fig. 2d and e). In all cases, the visual control of the matching scattergrams showed an interference of small erythrocytes and/or reticulocytes. Gate 4 was included in both the “Gelain-gate” and the “Pankraz-gate” but excluded in the “Oellers-gate”. In Fig. 3a and b, one of 30 samples with clinically important interferences and their impact on the r-PLT measurement performed with the different gating methods is shown.
Fig. 3

Samples of diseased dogs with suspected interferences. (a-b) Differences in the r-PLT percentage between the “Gelain-gate” (a) and the “Oellers-gate” (b) in a sample with suspected interferences of erythrocytes and reticulocytes. The white arrow shows the difference between the previously used gates and the novel “Oellers-gate”. (c) A sample with dots suspicious for WBC fragments appearing in the PLT-O channel and the gate for r-PLTs. Abbreviations: FSC, forward scatter; SFL, fluorescence intensity

Furthermore, in 6/362 samples, visual control of the scattergrams revealed a small number of dots other than r-PLTs displayed in all evaluated r-PLT gates (Fig. 3c). These dots were positioned underneath the r-PLT population and were consistent with white cell fragments described in humans. However, in the present study, they made up a negligible number of dots.

For measurement of r-PLTs in all three gates, intra-assay CVs > 22.0 % were obtained. The highest CV of 41.1 % was seen for the “Pankraz-gate”. CVs for PLT-O, PDW and PCT were 5.6, 6.8 and 4.5 % and thus markedly lower than for r-PLT measurement. For the variables MPV, P-LCR and PLT-I, CVs < 3 % were obtained (Table 4). However, in 18/25 measurements, results of the platelet indices MPV, PDW, P-LCR and PCT were not reported by the analyzer due to an error in (data) analysis, so that calculation of the CV was based on only 7 repeated measurements.
Table 4

Intra-assay repeatability of r-PLT and platelet indices using the Sysmex XT-2000iV

Variable

CV (%)

Mean ± SD

r-PLT “Gelain-gate”(%)

22.02

6.98 ± 1.54

r-PLT “Pankraz-gate”(%)

41.14

1.81 ± 0.75

r-PLT “Oellers-gate”(%)

22.04

7.02 ± 1.55

r-PLT “Gelain-gate”(× 109/L)

21.36

7.11 ± 1.52

r-PLT “Pankraz-gate”(× 109/L)

40.10

1.84 ± 0.74

r-PLT “Oellers-gate”(× 109/L)

21.38

7.1 ± 1.52

PLT-I (× 109/L)

2.98

128.32 ± 3.83

PLT-O (× 109/L)

5.56

121.2 ± 6.73

MPV (fL)

1.86

13.2 ± 0.24

PDW (fL)

6.75

17.77 ± 1.20

P-LCR (%)

2.72

47.7 ± 1.30

PCT (%)

4.52

0.17 ± 0.01

r-PLT, PLT-I, PLT-O: n = 25 repeated measurements

MPV, PDW, P-LCR, PCT: n = 7 repeated measurements

Abbreviations: CV coefficient of variation, SD standard deviation, PLT-I platelet count with impedance, PLT-O platelet count in optical fluorescence analysis, MPV mean platelet volume, PDW calculated distribution width of platelets, P-LCR platelet-large cell ratio, PCT plateletcrit, L liter, fL femtoliter

The reference intervals for r-PLTs obtained with the different gates are shown in Table 5. The corresponding data distribution is demonstrated in Fig. 4. Table 6 shows the reference ranges for platelet indices. Reference intervals obtained for all dogs irrespective of the breed, differed evidently from those calculated exclusively for the population of “Beagles” or “non-Beagles”. Overall, reference intervals established solely for the Beagle population showed the smallest range.
Table 5

Reference ranges for reticulated platelets (r-PLT) in healthy dogs independent of the breed as well as in Beagles and non-Beagles using the Sysmex XT-2000iV

Variable

All dogs (n = 193)

Beagles (n = 153)

Non-Beagles (n = 40)

 

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

r-PLT “Gelain-gate”(%)

0.2 (0.1–0.3)

3.7 (2.7–6.9)

Nonparametric

0.2 (0.1–0.3)

2.4 (2.1–4.5)

Nonparametric

0.2 (0.1–0.3)

6.8 (4.8–9.3)

Robust, Box-Cox-Transformation

r-PLT “Pankraz-gate”(%)

0.0 (0.0–0.0)

1.2 (1.0–2.2)

Nonparametric

0.0 (0.0–0.0)

1.0 (0.7–1.3)

Nonparametric

0.0 (0.0–0.0)

2.2 (1.6–2.8)

Robust, Box-Cox-Transformation

r-PLT “Oellers-gate”(%)

0.2 (0.1–0.3)

3.9 (2.8–7.0)

Nonparametric

0.2 (0.1–0.3)

2.4 (2.1–4.5)

Nonparametric

0.2 (0.1–0.3)

7.1 (5.0–9.7)

Robust, Box-Cox-Transformation

r-PLT “Gelain-gate”(× 109/L)

0.4 (0.3–0.6)

5.7 (4.9–8.7)

Nonparametric

0.4 (0.3–0.5)

4.2 (3.7–6.5)

Nonparametric

0.3 (0.1–0.4)

6.4 (5.0–8.0)

Robust, Box-Cox-Transformation

r-PLT “Pankraz-gate”(× 109/L)

0.1 (0.0–0.1)

2.1 (1.8–2.9)

Nonparametric

0.1 (0.0–0.1)

1.7 (1.4–2.2)

Nonparametric

0.0 (0.0–0.1)

3.2 (2.7–3.2)

Nonparametric

r-PLT “Oellers-gate”(× 109/L)

0.4 (0.3–0.6)

5.6 (4.9–8.7)

Nonparametric

0.4 (0.3–0.5)

4.2 (3.6–6.4)

Nonparametric

0.5 (0.3–0.7)

10.0 (7.5–12.6)

Robust, Box-Cox-Transformation

Abbreviations: CI confidence interval, for remainder abbreviations: see Table 4

Fig. 4

Reference interval and data distributions for r-PLTs of 193 healthy dogs measured with the Sysmex XT-2000iV and three different gating methods. Blue bars show the observed data distribution, the purple curve represents Gaussian fit. The blue vertical lines are consistent with the lower and upper limits of the reference interval; the dotted lines indicate the 90 % confidence interval. Abbreviations: r-PLT “Gelain-gate”: gate based on the publication of Gelain et al.; r-PLT “Pankraz-gate”: gate based on the publication of Pankraz et al., r-PLT “Oellers-gate”: optimized gate for measurement of r-PLTs

Table 6

Reference ranges for platelet indices in healthy dogs independent of the breed as well as in Beagles and non-Beagles using the Sysmex XT-2000iV

Variable

All dogs (n = 190–193)

Beagles (n = 152–153)

Non-Beagles (n = 38–40)

 

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

2.5th Percentile (90 % CI)

97.5th Percentile (90 % CI)

Method

PLT-I (× 109/L)

161.8 (149.0–175.0)

425.0 (381.0–438.0)

Non-parametric

176.7 (155.0–194.0)

406.9 (377.0–452.0)

Non-parametric

125.6 (115.5–143.7)

452.0 (405.3–501.8)

Robust, Box-Cox-Trans-formation

PLT-O (× 109/L)

150.9 (141.0–169.0)

397.5 (355.0–416.0)

Non-parametric

172.8 (161.0–184.0)

377.1 (351.0–416.0)

Non-parametric

121.6 (110.6–137.1)

418.9 (375.2–467.7)

Robust, Box-Cox-Trans-formation

MPV (fL)

8.6 (8.3–8.9)

12.5 (12.1–12.8)

Non-parametric

8.8 (8.6–8.9)

12.3 (12.1–13.4)

Non-parametric

7.9 (7.4–8.4)

12.8 (12.3–13.4)

Robust

PDW (fL)

8.8 (8.4–9.2)

16.6 (14.7–18.0)

Non-parametric

9.0 (8.7–9.3)

15.4 (14.5–18.0)

Non-parametric

7.9 (7.5–8.6)

18.3 (16.4–20.5)

Robust, Box-Cox-Transformation

P-LCR (%)

14.1 (12.1–15.9)

43.0 (41.3–44.7)

Non-parametric

15.5 (14.1–16.8)

43.1 (41.3–48.2)

Non-parametric

9.1 (5.3–13.1)

45.8 (41.5–49.8)

Parametric

PCT (%)

0.2 (0.2–0.2)

0.4 (0.4–0.4)

Non-parametric

0.2 (0.2–0.2)

0.4 (0.4–0.5)

Non-parametric

0.2 (0.1–0.2)

0.4 (0.4–0.5)

Robust, Box-Cox-Transformation

Abbreviations: CI confidence interval; for remainder abbreviations: see Table 4

In 3/193 healthy dogs (1/153 Beagle and 2/40 non-Beagle), platelet indices were not reported by the analyzer due to an error in (data) analysis so that these three samples could not be included in the calculation of the respective reference intervals.

Furthermore, the analyzer did not report a result for the platelet indices in samples with r-PLT percentages exceeding 11.61 % (19/362) for the “Gelain-gate” and 11.66 % (21/362) for the “Oellers-gate”, respectively. In samples without reported PLT indices, the platelet histogram was characterized by a relatively indistinctive separation (“valley”) between erythrocytes and platelets so that a reliable differentiation between the cellular populations could not be ensured by the analyzer’s software.

Discussion

Overall, the retrospective analysis of a large number of dog CBCs enabled us to optimize the already existing r-PLT gates by excluding interferences of reticulocytes and small erythrocytes with the r-PLT measurement.

The significant difference between the “Pankraz-gate” and the two other gates is presumably a result of its smaller size. Compared to the other gates, r-PLTs need to contain more RNA to be detected in the “Pankraz-gate”. Consequently, the corresponding reference ranges obtained for the “Pankraz-gate” are much narrower than for the other gates. The difference between the “Gelain-gate” and “Oellers-gate” was solely based on samples where erythrocytes and/or reticulocytes interfered with the measurement of platelets and r-PLTs. Using the “Gelain-gate”, these interfering erythrocytes and/or reticulocytes were incorrectly counted as mature platelets, consequently resulting in a false high total platelet count obtained with the manual gate and thus a false low percentage of r-PLTs. This incorrect cell count is only a problem of the manual gating technique; however, the original automated PLT count could not be used for the purposes of r-PLT measurement. In contrast, the effect of interferences, i.e., false low r-PLT counts, is minimized by the novel “Oellers-gate” by excluding the critical group of cellular populations (Fig. 3a and b).

Another reason for visual examination of the scattergrams is the occurrence of another type of interfering cells within the r-PLT-gate, which were rarely observed in the present study (Fig. 3c) but have not been described previously for dogs. In human medicine, similar interferences have been reported in patients receiving chemotherapy and were considered to be white cell fragments [20]. In our study, the definite origin and etiology of the interferences could not be evaluated.

The r-PLT reference intervals obtained in this study are consistent with the reference intervals published previously for the XT-2000iV [8, 9]. Reference intervals established here for the “Gelain-gate” (0.2–3.7 %; 0.4–5.7 × 109/L) and the “Oellers-gate” (0.2–3.9 %; 0.4–5.6 × 109/L) in 193 dogs are comparable with results published previously by Gelain et al. [9] (1.4 ± 0.7 %; 4 ± 2.5 × 109/L, n = 86). Furthermore, our reference interval established for the “Pankraz-gate” (0.0–1.2 %) is in accordance to the reference range shown previously by Pankraz et al. for the XT-2000iV [8] (0.56 ± 0.82 %, n = 40).

Our results clearly showed that the reference intervals in Beagle dogs are much smaller than in non-Beagle dogs, which is most likely because of the lower genetic variation, the similar age and the identical housing conditions.

Moreover, the reference intervals published by Smith et al. for flow cytometry with Thiazol Orange and CD61 [21] are also comparable (1.9 ± 1.2 %; 5.2 ± 3.4 × 109/L, n = 36) with our results. However, when regarding other reference intervals for r-PLTs determined flow-cytometrically with the Thiazol Orange method, there is a large discrepancy between results reported in the literature ranging from 3.4 ± 2.0 % (n = 8 dogs) [22] to 9.3 ± 2.7 % (n = 20 dogs) [23] and the respective reference intervals are generally higher than those obtained in our study. Overall, it is obvious that reference intervals for flow cytometry differ clearly between different studies, whereas reference intervals for the XT-2000iV using similar gates showed good accordance. A possible cause could be different methodology, i.e., variations in staining protocols or gating of r-PLTs in laboratories using flow cytometry [24].

Furthermore, our reference intervals for platelet indices (n = 190–193, depending on the variable) showed good accordance with reference ranges published before for the XT-2000iV (n = 160–182, n = 126–132, depending on the variable [19, 25]).

However, the study is limited by its retrospective nature so that a comparison with a reference method other than the previously published gates was not performed. For interpretation of the reference intervals, it has to be considered that the group of non-Beagle dogs is also smaller than recommended by the ASVCP [11] and reference intervals have to be therefore considered as a rough estimate.

Despite the optimization of the gating method described here, interferences could not be totally avoided. Only flow cytometric assessment of specifically antibody-labeled platelets would allow a definite distinction between platelets and other cellular populations. Another potential limitation of the gating method applied by us and the previous authors evaluating the r-PLT count measured by the Sysmex XT is that the gates are based on visual – and therefore subjective and potentially imprecise – assessment of the dot plots. Additionally, the position and size of the gates is fixed, so that in some samples, the shape of the gates did not entirely match the shape of the total platelet population. Thus, each measurement should be verified by visual examination of the scattergram. Ideally, algorithms would be generated to adapt the gate’s position to the properties of the platelet population.

Similar to results of previous studies using the Sysmex XT-2000iV, the platelet indices MPV, PDW, P-LCR and PCT [8, 19, 25] are frequently not reported by the analyzer. Because of the retrospective nature of this study, resampling was not possible so that the intra-assay repeatability could not be calculated for platelet indices, which is a limitation of this study. It should be noted that in samples with more than 11.61 % r-PLTs, as measured with the “Gelain-gate”, no platelet indices were given. Consequently, the platelet indices cannot be used to reflect presence of large numbers of young – presumably large - platelets and consequently a marked platelet regeneration as has been controversially discussed in previous studies [12, 16, 26, 27].

Conclusions

In conclusion, we managed to optimize the previously published gates by excluding interferences from erythrocytes. However, visual assessment of the scattergrams still remains necessary. Future improvement might be achieved by the generation of algorithms automatically adapting the gate to the position of the platelet population. The use of platelet indices as a marker of PLT regeneration is questionable as their measurement is often not reliably possible especially in samples with evidence of larger numbers of immature PLTs.

The reference intervals obtained from a large population of Beagle dogs for r-PLTs and platelet indices might become particularly useful for experimental studies using Beagles.

Declarations

Acknowledgements

We thank Sysmex Europe GmbH, Norderstedt, Germany, for kindly providing the Sysmex XT-2000iV hematology analyzer.

Funding

The authors received the following financial support for the research, authorship, and/or publication of this article: The Sysmex XT-2000iV hematology analyzer was provided as a loan by the Sysmex Company.

Availability of data and materials

Data will not be shared because of unpublished content.

Authors’ contributions

DO collected the data, created the gates, performed the statistical analysis and drafted the manuscript. NB performed the statistical analysis and participated in writing of the manuscript. MG participated the data collection and analysis. SJ was involved in project planning and discussion of the results. IP collected a great number of blood samples. AM conceived of the study and participated in its design and coordination. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Blood samples of healthy Beagle dogs were collected in accordance with Article 8 of German Law on the Protection of Animals and the Darmstadt Regional Council. In healthy and diseased dogs presented in the department of veterinary clinical sciences in Giessen, Germany, the hematology was part of the routine diagnostic procedure. According to the information of our ethics committee (ethics committee number: GI 17/18), a particular approval was not needed, because the study itself was not the indication of blood sampling and did not require taking an additional amount of blood.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Veterinary Clinical Sciences, Clinical Pathophysiology and Clinical Pathology, Justus-Liebig University Giessen
(2)
IDEXX BioResearch Europe, A Division of IDEXX Laboratories
(3)
Merck Serono, Global Non-Clinical Safety, Merck KGaA

References

  1. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Brit J Haematol. 1969;17:225–9.View ArticleGoogle Scholar
  2. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood. 1990;75:116–21.PubMedGoogle Scholar
  3. Lee LG, Chen C, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry. 1986;7:508–17.View ArticlePubMedGoogle Scholar
  4. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood. 1995;85:1822–5.PubMedGoogle Scholar
  5. Zucker ML, Murphy CA, Rachel JM, Martinez GA, Abhyankar S, McGuirk JP, et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol. 2006;12:125–30.View ArticlePubMedGoogle Scholar
  6. Saigo K, Sakota Y, Masuda Y, Matsunaga K, Takenokuchi M, Nishimura K, et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci. 2008;38:127–32.View ArticlePubMedGoogle Scholar
  7. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Brit J Haematol. 2004;126:93–9.View ArticleGoogle Scholar
  8. Pankraz A, Bauer N, Moritz A. Comparison of flow cytometry with the Sysmex XT2000iV automated analyzer for the detection of reticulated platelets in dogs. Vet Clin Pathol. 2009;38:30–8.View ArticlePubMedGoogle Scholar
  9. Gelain E, Tutino G, Rossi G, Bertazzolo W. High fluorescent platelets fraction in macrothrombocytopenic Norfolk terrier. Toulouse: 20th ECVIM-CA Annual Congress; 2010.Google Scholar
  10. Solberg HE. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem. 1987;25:337–42.PubMedGoogle Scholar
  11. Friedrichs K, Barnhart K, Blanco J, Freeman K, Harr K, Szladovits B, et al. Qualitiy Assurance and Laboratory Standards Commitee (QALS). Guidelines for the determination of reference intervals in veterinary species and other related topics: SCOPE. American Society of Veterinary Clinical Pathology (ASVCP). 2011.Google Scholar
  12. Bommer NX, Shaw DJ, Milne EM, Ridyard AE. Platelet distribution width and mean platelet volume in the interpretation of thrombocytopenia in dogs. J Small Anim Pract. 2008;49:518–24.View ArticlePubMedGoogle Scholar
  13. Joutsi-Korhonen L, Sainio S, Riikonen S, Javela K, Teramo K, Kekomäki R. Detection of reticulated platelets: estimating the degree of fluorescence of platelets stained with thiazole orange. Eur J Haematol. 2000;65:66–71.View ArticlePubMedGoogle Scholar
  14. O’Malley CJ, Rasko JEJ, Basser RL, McGrath KM, Cebon J, Grigg AP, et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood. 1996;88:3288–98.PubMedGoogle Scholar
  15. Kickler TS, Oguni S, Borowitz MJ. A clinical evaluation of high fluorescent platelet fraction percentage in thrombocytopenia. Am J Clin Pathol. 2006;125:282–7.View ArticlePubMedGoogle Scholar
  16. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Brit J Haematol. 2005;128:698–702.View ArticleGoogle Scholar
  17. Ogura M, Yasuno M, Kobayashi Y, Tsukada T. Clinical significance of platelet volume indices estimated by automated blood cell analyzer. Rinsho Byori. 1995;43:385–90.PubMedGoogle Scholar
  18. Schwartz D, Sharkey L, Armstrong PJ, Knudson C, Kelley J. Platelet volume and plateletcrit in dogs with presumed primary immune-mediated thrombocytopenia. J Vet Intern Med. 2014;28:1575–9.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Bourgès-Abella N, Geffré A, Concordet D, Braun J, Trumel C. Canine reference intervals for the Sysmex XT-2000iV hematology analyzer. Vet Clin Pathol. 2011;40:303–15.View ArticlePubMedGoogle Scholar
  20. Rowan RM, Linssen J. A picture is worth a thousand words. Sysmex J Int. 2005;15(1):27–32.Google Scholar
  21. Smith R, Thomas JS. Quantitation of reticulated platelets in healthy dogs and in nonthrombocytopenic dogs with clinical disease. Vet Clin Pathol. 2002;31:26–32.View ArticlePubMedGoogle Scholar
  22. Hanahachi A, Moritomo T, Kano R, Watari T, Tsujimoto H, Hasegawa A. Thiazole orange-positive platelets in healthy and thrombocytopenic dogs. Vet Rec. 2001;149:122–3.View ArticlePubMedGoogle Scholar
  23. Weiss DJ, Townsend E. Evaluation of reticulated platelets in dogs. Comp Haematol Int. 1998;8:166–70.View ArticleGoogle Scholar
  24. Schmitz G, Rothe G, Ruf A, Barlage S, Tschöpe D, Clemetson KJ, et al. European Working Group on Clinical Cell Analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost. 1998;79:885–96.PubMedGoogle Scholar
  25. Serra M, Freeman KP, Campora C, Sacchini F. Establishment of canine hematology reference intervals for the Sysmex XT-2000iV hematology analyzer using a blood donor database. Vet Clin Pathol. 2012;41:207–15.View ArticlePubMedGoogle Scholar
  26. Balduini CL, Noris P, Spedini P, Belletti S, Zambelli A, Da Prada GA. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Brit J Haematol. 1999;106:202–7.View ArticleGoogle Scholar
  27. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol. 2005;27:370–3.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement